CD4 and hepatotoxicity: Liver toxicity associated with nevirapine is supposed to occur more frequently in the first 18 weeks of treatment, and in our study grade ≥ 2 early toxicity occurred almost exclusively among women with baseline CD4+ count > 250/mm3.